181 related articles for article (PubMed ID: 15611073)
21. An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation.
Schoeberl B; Faber AC; Li D; Liang MC; Crosby K; Onsum M; Burenkova O; Pace E; Walton Z; Nie L; Fulgham A; Song Y; Nielsen UB; Engelman JA; Wong KK
Cancer Res; 2010 Mar; 70(6):2485-94. PubMed ID: 20215504
[TBL] [Abstract][Full Text] [Related]
22. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
Mendrola JM; Berger MB; King MC; Lemmon MA
J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
[TBL] [Abstract][Full Text] [Related]
23. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
Li Z; Mei Y; Liu X; Zhou M
Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
[TBL] [Abstract][Full Text] [Related]
25. Dynamically varying interactions between heregulin and ErbB proteins detected by single-molecule analysis in living cells.
Hiroshima M; Saeki Y; Okada-Hatakeyama M; Sako Y
Proc Natl Acad Sci U S A; 2012 Aug; 109(35):13984-9. PubMed ID: 22891299
[TBL] [Abstract][Full Text] [Related]
26. Structure of the extracellular region of HER3 reveals an interdomain tether.
Cho HS; Leahy DJ
Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
[TBL] [Abstract][Full Text] [Related]
27. Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2 and p85.
Gamett DC; Greene T; Wagreich AR; Kim HH; Koland JG; Cerione RA
J Biol Chem; 1995 Aug; 270(32):19022-7. PubMed ID: 7642563
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3.
Chen CH; Chernis GA; Hoang VQ; Landgraf R
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9226-31. PubMed ID: 12874383
[TBL] [Abstract][Full Text] [Related]
29. Ligand-induced structural transitions in ErbB receptor extracellular domains.
Dawson JP; Bu Z; Lemmon MA
Structure; 2007 Aug; 15(8):942-54. PubMed ID: 17697999
[TBL] [Abstract][Full Text] [Related]
30. Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016.
Xia W; Liu LH; Ho P; Spector NL
Oncogene; 2004 Jan; 23(3):646-53. PubMed ID: 14737100
[TBL] [Abstract][Full Text] [Related]
31. Disabling receptor ensembles with rationally designed interface peptidomimetics.
Berezov A; Chen J; Liu Q; Zhang HT; Greene MI; Murali R
J Biol Chem; 2002 Aug; 277(31):28330-9. PubMed ID: 12011054
[TBL] [Abstract][Full Text] [Related]
32. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
Ishizawar RC; Miyake T; Parsons SJ
Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
[TBL] [Abstract][Full Text] [Related]
33. Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
Kawano S; Ikeda W; Kishimoto M; Ogita H; Takai Y
J Biol Chem; 2009 Aug; 284(35):23793-805. PubMed ID: 19561085
[TBL] [Abstract][Full Text] [Related]
34. Replacement of N-terminal portions of TGF-alpha with corresponding heregulin sequences affects ligand-induced receptor signaling and intoxication of tumor cells by chimeric growth-factor toxins.
Schmidt M; Wels W
Int J Cancer; 2002 Jan; 97(3):349-56. PubMed ID: 11774287
[TBL] [Abstract][Full Text] [Related]
35. Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells.
Ueno Y; Sakurai H; Tsunoda S; Choo MK; Matsuo M; Koizumi K; Saiki I
Int J Cancer; 2008 Jul; 123(2):340-347. PubMed ID: 18398842
[TBL] [Abstract][Full Text] [Related]
36. Interaction of integrin alpha(6)beta(4) with ErbB3 and implication in heregulin-induced ErbB3/ErbB2-mediated DNA synthesis.
Kawano S; Mizutani K; Miyata M; Ikeda W; Takai Y
Genes Cells; 2010 Sep; 15(9):995-1001. PubMed ID: 20695903
[TBL] [Abstract][Full Text] [Related]
37. Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes.
Carver RS; Sliwkowski MX; Sitaric S; Russell WE
J Biol Chem; 1996 Jun; 271(23):13491-6. PubMed ID: 8662847
[TBL] [Abstract][Full Text] [Related]
38. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
Alimandi M; Romano A; Curia MC; Muraro R; Fedi P; Aaronson SA; Di Fiore PP; Kraus MH
Oncogene; 1995 May; 10(9):1813-21. PubMed ID: 7538656
[TBL] [Abstract][Full Text] [Related]
39. ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration.
Gambarotta G; Garzotto D; Destro E; Mautino B; Giampietro C; Cutrupi S; Dati C; Cattaneo E; Fasolo A; Perroteau I
J Biol Chem; 2004 Nov; 279(47):48808-16. PubMed ID: 15355992
[TBL] [Abstract][Full Text] [Related]
40. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis.
Smirnova T; Zhou ZN; Flinn RJ; Wyckoff J; Boimel PJ; Pozzuto M; Coniglio SJ; Backer JM; Bresnick AR; Condeelis JS; Hynes NE; Segall JE
Oncogene; 2012 Feb; 31(6):706-15. PubMed ID: 21725367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]